Biopolymeric microparticles combined with lyophilized monophase dispersions for controlled flutamide release

International Journal of Pharmaceutics

Volumn 411, Issue 1-2, 2011, Pages 113-120

  Elgindy, Nazik ^a   Elkhodairy, Kadria ^a   Molokhia, Abdallah ^b   Elzoghby, Ahmed ^a  

^a Alexandria University Faculty of Pharmacy   (Egypt)

^b Quality Control Department   (Egypt)

Author keywords

Chitosan microparticles; Controlled release; Emulsification; Flutamide; Ionic gelation; Lyophilization monophase solution

Indexed keywords

BIOPOLYMER; CHITOSAN; DRUG VEHICLE; FLUTAMIDE;

ARTICLE; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY SYSTEM; DRUG RETENTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; MEMBRANE MICROPARTICLE; MICROENCAPSULATION; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS, HORMONAL; BIOCOMPATIBLE MATERIALS; CALORIMETRY, DIFFERENTIAL SCANNING; CHITOSAN; DELAYED-ACTION PREPARATIONS; DRUG COMPOUNDING; EXCIPIENTS; FLUTAMIDE; FREEZE DRYING; PARTICLE SIZE; PHARMACEUTICAL SOLUTIONS; POLYMERS; SOLUBILITY;

EID: 79955965567     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2011.03.047     Document Type: Article

References (28)

1. Adel, M.S., Geneidi, A.S., Shoukri, R.A., Saad, I., 1997. In vitro evaluation of flutamide carrier systems: Part 1: preparation and evaluation of flutamide systems with polyvinyl pyrrolidone and polyethylene glycol 4000 and 6000. Pharmazie 52, 373-375.
2. Anal, A.K., Stevens, W.F., Remunan-Lopez, C., 2006. Ionotropic cross-linked chitosan microspheres for controlled release of ampicillin. Int. J. Pharm. 312, 166-173.
3. Babu, V.R., Hosamani, K.M., Aminabhavi, T.M., 2008. Preparation and in-vitro release of chlorothiazide novel pH-sensitive chitosan-N,N- dimethylacrylamide semi-interpenetrating network microspheres. Carbohydr. Polym. 71, 208-217.
4. Bodmeier, R., Oh, K.H., Pramar, Y., 1989. Preparation and evaluation of drug-containing chitosan beads. Drug Dev. Ind. Pharm. 15, 1475-1494.
5. Debruyna, F.M.I., 1996. Combined androgen blockade is the treatment of choice for patients with advanced prostate cancer. Eur. Urol. 29, 34-36.
6. Denis, L., 1995. Commentary on maximum androgen blockade in prostate cancer: a theory to put into practice? The prostate 27, 233-240.
7. Dhawan, S., Singla, A.K., 2003. Nifedipine loaded chitosan microspheres prepared by emulsification phase-separation. Biotech. Histochem. 78, 243-254.
8. Dini, E., Alexandridou, S., Kiparissides, C., 2001. Synthesis and characterization of crosslinked microparticles for drug delivery. Chimia 55, 239-241.
9. Elgibaly, I., Meki, A.M., Abdel-Ghaffar, S.K., 2003. Novel Bmelatonin-loaded chitosan microcapsules: in vitro characterization and antiapoptosis efficacy for aflatoxin B1-induced apoptosis in rat liver. Int. J. Pharm. 260, 5-22.
10. Elgindy, N., Elkhodairy, K., Molokhia, A., Elzoghby, A., 2010. Lyophilization monophase solution technique for improvement of the physicochemical properties of an anticancer drug, flutamide. Eur. J. Pharm. Biopharm. 74, 397-405.
11. Elgindy, N., Elkhodairy, K., Molokhia, A., Elzoghby, A., 2011a. Lyophilization monophase solution technique for preparation of amorphous flutamide dispersions. Drug Dev. Ind. Pharm. 1-11, 539232, doi:10.3109/03639045. 2010.
12. Elgindy, N., Elkhodairy, K., Molokhia, A., Elzoghby, A., 2011b. Lyophilized flutamide dispersions with polyols and aminoacids: preparation and in-vitro evaluation. Drug Dev. Ind. Pharm. 37, 446-455.
13. F.I.P., 1996. FIP guidelines for dissolution testing of solid oral products (final drafts, 1995). Drug Inf. J. 30, 1071-1084.
14. Govender, S., Lutchman, D., Pillay, V., Chetty, D.J., Govender, T., 2006. Enhancing drug incorporation into tetracycline-loaded chitosan microspheres for periodontal therapy. J. Microencapsul. 23, 750-761. (Pubitemid 44811438)
15. Gupta, K.C., Ravi-Kumar, M.N.V., 2000. Drug release behavior of beads and micro-granules of chitosan. Biomaterials 21, 1115-1119. (Pubitemid 30173149)
16. Hekmatara, T., Regdon, G.J., Sipos, P., Erocombining double acute accents, I., Pintye-Hódi, K., 2006. Thermoanalytical study of microspheres containing diltiazem hydrochloride. J. Therm. Anal. Calorim. 86, 287-290.
17. Huang, J., Wigent, R.J., Schwartz, J.B., 2006. Nifedipine molecular dispersion in microparticles of ammonio methacrylate copolymer and ethylcellulose binary blends for controlled drug delivery: effect of matrix composition. Drug Dev. Ind. Pharm. 32, 1185-1197.
18. Jingjun, H., Rodney, J., Catherine, M., Joseph, B., 2006. Nifedipine solid dispersion in microparticles of ammonio methacrylate copolymer and ethylcellulose binary blend for controlled drug delivery: effect of drug loading on release kinetics. Int. J. Pharm. 319, 44-54.
19. Ko, J.A., Park, H.J., Hwang, S.J., Park, J.B., Lee, J.S., 2002. Preparation and characterization of chitosan microparticles intended for controlled drug delivery. Int. J. Pharm. 249, 165-174.
20. Lang, B., 1971. In vitro drug release rate as a standard requirement. Die Biopharm., 661-664.
21. Lim, L.Y., Wan, L.S.C., Thai, P.Y., 1997. Chitosan microspheres prepared by emulsification and ionotropic gelation. Drug Dev. Ind. Pharm. 23, 981-985.
22. Maestrelli, F., García-Fuentes, M., Mura, P., Alonso, M.J., 2006.Anewdrug nanocarrier consisting of chitosan and hydroxypropylcyclodextrin. Eur. J. Pharm. Biopharm. 63, 79-86.
23. Nari, R., 1989. Pharmacology and pharmacokinetics of flutamide. Urology 34, 19-21.
24. Shiraishi, S., Imai, T., Otagiri, M., 1993. Controlled release of indomethacin by chitosan-polyelectrolyte complex: optimization and in vivo/in vitro evaluation. J. Control. Release 25, 217-225. (Pubitemid 23181333)
25. Sinha, V.R., Singla, A.K., Wadhawan, S., Kaushik, R., Kumria, R., Bansal, K., Dhawan, S., 2004. Chitosan microspheres as a potential carrier for drugs. Int. J. Pharm. 274, 1-33.
26. Umrethia, M.L., Ghosh, P.K., Majithiya, R.J., Murthy, R.S.R., 2005. A new reverse-phase high performance liquid chromatographic method for determination of flutamide in liposomes, rat blood plasma and tablet dosage forms. Ars Pharm. 46, 109-124. (Pubitemid 41285634)
27. Ventura, C.A., Tommasini, S., Crupi, E., Giannone, I., Cardile, V., Musumeci, T., Puglisi, G., 2008. Chitosan microspheres for intrapulmonary administration of moxifloxacin: interaction with biomembrane models and in vitro permeation studies. Eur. J. Pharm. Biopharm. 68, 235-244.
28. Zuo, Z., Tam, Y.K., Diakur, J., Wiebe, L.I., 2002. Hydroxypropyl-β- cyclodextrin flutamide inclusion complex. II. Oral and intravenous pharmacokinetics of flutamide in rat. J. Pharm. Pharm. Sci. 5, 292-298.